{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:58Z","timestamp":1790016958388,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FFSG-2024-0020"],"award-info":[{"award-number":["FFSG-2024-0020"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02450-4","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:34:11Z","timestamp":1767854051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective Study of the Physiological and Molecular Features of the S-FUS (1-359) Mouse Transgenic Model with an ALS-like Phenotype: Lifespan, Body Weight Dynamics, Movement Disorders, and Dysregulation of the Dopaminergic System"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-0729","authenticated-orcid":false,"given":"Evgeny","family":"Bronovitsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Chaprov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Khizeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Pravdivceva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofey","family":"Bobkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Krayushkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Nebogatikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ninkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey","family":"Ustyugov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2450_CR1","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1038\/s41598-019-41040-4","volume":"9","author":"MA Ajmone-Cat","year":"2019","unstructured":"Ajmone-Cat MA, Onori A, Toselli C et al (2019) Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci Rep 9:4572. https:\/\/doi.org\/10.1038\/s41598-019-41040-4","journal-title":"Sci Rep"},{"key":"2450_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-019-0658-x","volume":"7","author":"H An","year":"2019","unstructured":"An H, Skelt L, Notaro A et al (2019) ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun 7:7. https:\/\/doi.org\/10.1186\/s40478-019-0658-x","journal-title":"Acta Neuropathol Commun"},{"key":"2450_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","volume":"7","author":"PM Andersen","year":"2011","unstructured":"Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7:603\u2013615. https:\/\/doi.org\/10.1038\/nrneurol.2011.150","journal-title":"Nat Rev Neurol"},{"key":"2450_CR4","doi-asserted-by":"publisher","first-page":"45627","DOI":"10.1038\/srep45627","volume":"7","author":"SO Bachurin","year":"2017","unstructured":"Bachurin SO, Shevtsova EF, Makhaeva GF et al (2017) Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. Sci Rep 7:45627. https:\/\/doi.org\/10.1038\/srep45627","journal-title":"Sci Rep"},{"key":"2450_CR5","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.3390\/ijms232213925","volume":"23","author":"SO Bachurin","year":"2022","unstructured":"Bachurin SO, Shevtsova EF, Makhaeva GF et al (2022) Conjugates of methylene blue with cycloalkaneindoles as new multifunctional agents for potential treatment of neurodegenerative disease. Int J Mol Sci 23:13925. https:\/\/doi.org\/10.3390\/ijms232213925","journal-title":"Int J Mol Sci"},{"key":"2450_CR6","doi-asserted-by":"publisher","first-page":"12236","DOI":"10.3390\/ijms222212236","volume":"22","author":"T Bonifacino","year":"2021","unstructured":"Bonifacino T, Zerbo RA, Balbi M et al (2021) Nearly 30 years of animal models to study amyotrophic lateral sclerosis: a historical overview and future perspectives. Int J Mol Sci 22:12236. https:\/\/doi.org\/10.3390\/ijms222212236","journal-title":"Int J Mol Sci"},{"key":"2450_CR7","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.1503\/cmaj.191236","volume":"192","author":"A Breiner","year":"2020","unstructured":"Breiner A, Zinman L, Bourque PR (2020) Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics. CMAJ 192:E319\u2013E320. https:\/\/doi.org\/10.1503\/cmaj.191236","journal-title":"CMAJ"},{"key":"2450_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/WCO.0000000000001093","volume":"35","author":"D Brenner","year":"2022","unstructured":"Brenner D, Freischmidt A (2022) Update on genetics of amyotrophic lateral sclerosis. Curr Opin Neurol 35:672\u2013677. https:\/\/doi.org\/10.1097\/WCO.0000000000001093","journal-title":"Curr Opin Neurol"},{"key":"2450_CR9","doi-asserted-by":"publisher","unstructured":"Bronovitsky EV, Deikin AV, Ermolkevich TG et al (2015) Gamma-carboline inhibits neurodegenerative processes in a transgenic model of amyotrophic lateral sclerosis. Dokl Biochem Biophys. https:\/\/doi.org\/10.1134\/S1607672915030138","DOI":"10.1134\/S1607672915030138"},{"key":"2450_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/cns.13637","volume":"27","author":"K Chaprov","year":"2021","unstructured":"Chaprov K, Rezvykh A, Funikov S et al (2021) A bioisostere of Dimebon\/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice. CNS Neurosci Ther 27:765. https:\/\/doi.org\/10.1111\/cns.13637","journal-title":"CNS Neurosci Ther"},{"key":"2450_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neurol.2020.06.010","volume":"177","author":"L Chen","year":"2021","unstructured":"Chen L (2021) FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Rev Neurol (Paris) 177:333\u2013340. https:\/\/doi.org\/10.1016\/j.neurol.2020.06.010","journal-title":"Rev Neurol (Paris)"},{"key":"2450_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s12276-021-00646-3","volume":"53","author":"H-U Cho","year":"2021","unstructured":"Cho H-U, Kim S, Sim J et al (2021) Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Exp Mol Med 53:1148\u20131158. https:\/\/doi.org\/10.1038\/s12276-021-00646-3","journal-title":"Exp Mol Med"},{"key":"2450_CR13","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1007\/s12035-022-03042-8","volume":"59","author":"G Chopra","year":"2022","unstructured":"Chopra G, Shabir S, Yousuf S et al (2022) Proteinopathies: deciphering physiology and mechanisms to develop effective therapies for neurodegenerative diseases. Mol Neurobiol 59:7513\u20137540. https:\/\/doi.org\/10.1007\/s12035-022-03042-8","journal-title":"Mol Neurobiol"},{"key":"2450_CR14","unstructured":"Darrell Hulisz P (2018) Amyotrophic lateral sclerosis: disease state overview. 24:15"},{"key":"2450_CR15","unstructured":"Deykin AV, Kovrazhkina EK, Ovchinnikov RK, et al (2014) A mice model of amyotrophic lateral sclerosis expressing mutant human FUS protein. Zhurnal Nevrol Psihiatr Im SS Korsakova 114(8):62\u201369"},{"key":"2450_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/jnnp-2013-307135","volume":"85","author":"A Eisen","year":"2014","unstructured":"Eisen A, Kiernan M, Mitsumoto H, Swash M (2014) Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 85:1232\u20131238. https:\/\/doi.org\/10.1136\/jnnp-2013-307135","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2450_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S et al (2022) Amyotrophic lateral sclerosis. Lancet 400:1363\u20131380. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7","journal-title":"Lancet"},{"key":"2450_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-023-00619-2","volume":"18","author":"EMC Fisher","year":"2023","unstructured":"Fisher EMC, Greensmith L, Malaspina A et al (2023) Opinion: more mouse models and more translation needed for ALS. Mol Neurodegener 18:30. https:\/\/doi.org\/10.1186\/s13024-023-00619-2","journal-title":"Mol Neurodegener"},{"key":"2450_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/S10048-018-0553-9","volume":"19","author":"SY Funikov","year":"2018","unstructured":"Funikov SY, Rezvykh AP, Mazin PV et al (2018) FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics 19:189\u2013204. https:\/\/doi.org\/10.1007\/S10048-018-0553-9","journal-title":"Neurogenetics"},{"key":"2450_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.14336\/AD.2013.0400295","volume":"4","author":"PH Gordon","year":"2013","unstructured":"Gordon PH (2013) Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 4:295\u2013310. https:\/\/doi.org\/10.14336\/AD.2013.0400295","journal-title":"Aging Dis"},{"key":"2450_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1134\/S0006297919100055","volume":"84","author":"UA Gutner","year":"2019","unstructured":"Gutner UA, Shupik MA, Maloshitskaya OA et al (2019) Changes in the metabolism of sphingoid bases in the brain and spinal cord of transgenic FUS(1-359) mice, a model of amyotrophic lateral sclerosis. Biochemistry (Mosc) 84:1166\u20131176. https:\/\/doi.org\/10.1134\/S0006297919100055","journal-title":"Biochemistry (Mosc)"},{"key":"2450_CR22","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1111\/febs.16175","volume":"289","author":"H Hartmann","year":"2022","unstructured":"Hartmann H, Ho WY, Chang J-C, Ling S-C (2022) Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon? FEBS J 289:7688\u20137709. https:\/\/doi.org\/10.1111\/febs.16175","journal-title":"FEBS J"},{"key":"2450_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbi.2023.01.013","volume":"109","author":"I Jeric\u00f3","year":"2023","unstructured":"Jeric\u00f3 I, Vicu\u00f1a-Urriza J, Blanco-Luquin I et al (2023) Profiling TREM2 expression in amyotrophic lateral sclerosis. Brain Behav Immun 109:117\u2013126. https:\/\/doi.org\/10.1016\/j.bbi.2023.01.013","journal-title":"Brain Behav Immun"},{"key":"2450_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.23298","volume":"66","author":"A Kia","year":"2018","unstructured":"Kia A, McAvoy K, Krishnamurthy K et al (2018) Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66:1016\u20131033. https:\/\/doi.org\/10.1002\/glia.23298","journal-title":"Glia"},{"key":"2450_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","volume":"28","author":"VA Korobeynikov","year":"2022","unstructured":"Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B et al (2022) Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med 28:104\u2013116. https:\/\/doi.org\/10.1038\/s41591-021-01615-z","journal-title":"Nat Med"},{"key":"2450_CR26","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.3390\/molecules28227567","volume":"28","author":"MA Lapshina","year":"2023","unstructured":"Lapshina MA, Shevtsova EF, Grigoriev VV et al (2023) New adamantane-containing edaravone conjugates as potential neuroprotective agents for ALS treatments. Molecules 28:7567. https:\/\/doi.org\/10.3390\/molecules28227567","journal-title":"Molecules"},{"key":"2450_CR27","doi-asserted-by":"publisher","first-page":"P4.4-013","DOI":"10.1212\/WNL.92.15_supplement.P4.4-013","volume":"92","author":"I Lee","year":"2019","unstructured":"Lee I, Kazamel M, King P (2019) Fat mass loss correlates with survival in amyotrophic lateral sclerosis patients: prospective cohort study (P4.4-013). Neurology 92:P4.4-013. https:\/\/doi.org\/10.1212\/WNL.92.15_supplement.P4.4-013","journal-title":"Neurology"},{"key":"2450_CR28","doi-asserted-by":"publisher","first-page":"114780","DOI":"10.1016\/j.ecoenv.2023.114780","volume":"255","author":"G Li","year":"2023","unstructured":"Li G, Wang K, Zuo K et al (2023) TDP-43 is a potential marker of dopaminergic neuronal damage caused by atrazine exposure. Ecotoxicol Environ Saf 255:114780. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114780","journal-title":"Ecotoxicol Environ Saf"},{"key":"2450_CR29","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1038\/s41598-022-16229-9","volume":"12","author":"J-Y Li","year":"2022","unstructured":"Li J-Y, Sun X-H, Cai Z-Y et al (2022) Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Sci Rep 12:13292. https:\/\/doi.org\/10.1038\/s41598-022-16229-9","journal-title":"Sci Rep"},{"key":"2450_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s11064-020-02999-z","volume":"45","author":"EA Lysikova","year":"2020","unstructured":"Lysikova EA, Funikov S, Rezvykh AP et al (2020) Low level of expression of C-terminally truncated human FUS causes extensive changes in the spinal cord transcriptome of asymptomatic transgenic mice. Neurochem Res 45:1168\u20131179. https:\/\/doi.org\/10.1007\/s11064-020-02999-z","journal-title":"Neurochem Res"},{"key":"2450_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12607","author":"EA Lysikova","year":"2019","unstructured":"Lysikova EA, Kukharsky MS, Chaprov KD et al (2019) Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration. Genes Brain Behav. https:\/\/doi.org\/10.1111\/gbb.12607","journal-title":"Genes Brain Behav"},{"key":"2450_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.15252\/emmm.201607052","volume":"9","author":"JF Ma","year":"2017","unstructured":"Ma JF, Sanchez BJ, Hall DT et al (2017) STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner. EMBO Mol Med 9:622\u2013637. https:\/\/doi.org\/10.15252\/emmm.201607052","journal-title":"EMBO Mol Med"},{"key":"2450_CR33","doi-asserted-by":"publisher","first-page":"13269","DOI":"10.1093\/nar\/gkae942","volume":"52","author":"D Mariani","year":"2024","unstructured":"Mariani D, Setti A, Castagnetti F et al (2024) ALS-associated FUS mutation reshapes the RNA and protein composition of stress granules. Nucleic Acids Res 52:13269\u201313289. https:\/\/doi.org\/10.1093\/nar\/gkae942","journal-title":"Nucleic Acids Res"},{"key":"2450_CR34","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Damme PV (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27:1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"key":"2450_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jns.2019.02.030","volume":"399","author":"S Mathis","year":"2019","unstructured":"Mathis S, Goizet C, Soulages A et al (2019) Genetics of amyotrophic lateral sclerosis: a review. J Neurol Sci 399:217\u2013226. https:\/\/doi.org\/10.1016\/j.jns.2019.02.030","journal-title":"J Neurol Sci"},{"key":"2450_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia C, Calvo A, Grassano M et al (2019) Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry 90:666\u2013673. https:\/\/doi.org\/10.1136\/jnnp-2018-319611","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2450_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/21646821.2015.1075181","volume":"55","author":"J Morris","year":"2015","unstructured":"Morris J (2015) Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: an overview. The Neurodiagnostic Journal 55:180\u2013194. https:\/\/doi.org\/10.1080\/21646821.2015.1075181","journal-title":"The Neurodiagnostic Journal"},{"key":"2450_CR38","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.3390\/ijms24109022","volume":"24","author":"MA Mukhamedyarov","year":"2023","unstructured":"Mukhamedyarov MA, Khabibrakhmanov AN, Khuzakhmetova VF et al (2023) Early alterations in structural and functional properties in the neuromuscular junctions of mutant FUS mice. Int J Mol Sci 24:9022. https:\/\/doi.org\/10.3390\/ijms24109022","journal-title":"Int J Mol Sci"},{"key":"2450_CR39","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1038\/s41598-018-33964-0","volume":"8","author":"T Nakaya","year":"2018","unstructured":"Nakaya T, Maragkakis M (2018) Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci Rep 8:15575. https:\/\/doi.org\/10.1038\/s41598-018-33964-0","journal-title":"Sci Rep"},{"key":"2450_CR40","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/ijms23084453","volume":"23","author":"M-H Nam","year":"2022","unstructured":"Nam M-H, Sa M, Ju YH et al (2022) Revisiting the role of astrocytic MAOB in Parkinson\u2019s disease. Int J Mol Sci 23:4453. https:\/\/doi.org\/10.3390\/ijms23084453","journal-title":"Int J Mol Sci"},{"key":"2450_CR41","unstructured":"Nebogatikov V, Teterina E, Drutskaya M et al (2021) Cytokin\u0435 profiling of FUS-transgenic mice with Amyotrophic Lateral Sclerosis."},{"key":"2450_CR42","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/ijms22031085","volume":"22","author":"A Noor","year":"2021","unstructured":"Noor A, Zafar S, Zerr I (2021) Neurodegenerative proteinopathies in the proteoform spectrum\u2014tools and challenges. Int J Mol Sci 22:1085. https:\/\/doi.org\/10.3390\/ijms22031085","journal-title":"Int J Mol Sci"},{"key":"2450_CR43","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","volume":"32","author":"RS Peter","year":"2017","unstructured":"Peter RS, Rosenbohm A, Dupuis L et al (2017) Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol 32:901\u2013908. https:\/\/doi.org\/10.1007\/s10654-017-0318-z","journal-title":"Eur J Epidemiol"},{"key":"2450_CR44","doi-asserted-by":"publisher","unstructured":"Rasool A, Manzoor R, Ullah K, et al (2024) Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies. CNS Neurol Disord Drug Targets 23:852\u2013864. https:\/\/doi.org\/10.2174\/1871527322666230609141519","DOI":"10.2174\/1871527322666230609141519"},{"key":"2450_CR45","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1134\/S0006297924140037","volume":"89","author":"A Rezvykh","year":"2024","unstructured":"Rezvykh A, Shteinberg D, Bronovitsky E et al (2024) Animal models of FUS-proteinopathy: a systematic review. Biochemistry (Moscow) 89:S34\u2013S56. https:\/\/doi.org\/10.1134\/S0006297924140037","journal-title":"Biochemistry (Moscow)"},{"key":"2450_CR46","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1093\/nar\/gkad319","volume":"51","author":"AP Rezvykh","year":"2023","unstructured":"Rezvykh AP, Ustyugov AA, Chaprov KD et al (2023) Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology. Nucleic Acids Res 51:5810. https:\/\/doi.org\/10.1093\/nar\/gkad319","journal-title":"Nucleic Acids Res"},{"key":"2450_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-023-00380-y","volume":"12","author":"PJ Richardson","year":"2023","unstructured":"Richardson PJ, Smith DP, de Giorgio A et al (2023) Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. Transl Neurodegener 12:47. https:\/\/doi.org\/10.1186\/s40035-023-00380-y","journal-title":"Transl Neurodegener"},{"key":"2450_CR48","doi-asserted-by":"publisher","first-page":"25266","DOI":"10.1074\/jbc.M113.492017","volume":"288","author":"TA Shelkovnikova","year":"2013","unstructured":"Shelkovnikova TA, Peters OM, Deykin AV et al (2013) Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J Biol Chem 288:25266\u201325274. https:\/\/doi.org\/10.1074\/jbc.M113.492017","journal-title":"J Biol Chem"},{"key":"2450_CR49","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3109\/00207454.2015.1074902","volume":"126","author":"M Shrivastava","year":"2016","unstructured":"Shrivastava M, Subbiah V (2016) Elevated caspase 3 activity and cytosolic cytochrome c in NT2 cybrids containing amyotrophic lateral sclerosis subject mtDNA. Int J Neurosci 126:839\u2013849. https:\/\/doi.org\/10.3109\/00207454.2015.1074902","journal-title":"Int J Neurosci"},{"key":"2450_CR50","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S (2018) Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 21:1332. https:\/\/doi.org\/10.1038\/s41593-018-0235-9","journal-title":"Nat Neurosci"},{"key":"2450_CR51","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668. https:\/\/doi.org\/10.1126\/science.1154584","journal-title":"Science"},{"key":"2450_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-022-00591-3","volume":"18","author":"K Stoklund Dittlau","year":"2023","unstructured":"Stoklund Dittlau K, Terrie L, Baatsen P et al (2023) FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Mol Neurodegener 18:5. https:\/\/doi.org\/10.1186\/s13024-022-00591-3","journal-title":"Mol Neurodegener"},{"key":"2450_CR53","doi-asserted-by":"publisher","unstructured":"Takahashi H, Snow BJ, Bhatt MH et al (1993) Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342(8878):1016\u20131018. https:\/\/doi.org\/10.1016\/0140-6736(93)92878-w","DOI":"10.1016\/0140-6736(93)92878-w"},{"key":"2450_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1101\/gad.335836.119","volume":"34","author":"Y-L Tsai","year":"2020","unstructured":"Tsai Y-L, Coady TH, Lu L et al (2020) ALS\/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev 34:785\u2013805. https:\/\/doi.org\/10.1101\/gad.335836.119","journal-title":"Genes Dev"},{"key":"2450_CR55","doi-asserted-by":"publisher","unstructured":"Ustyugov AA, Shelkovnikova TA, Kokhan VS et al (2012) Dimebon reduces the levels of aggregated amyloidogenic protein forms in detergent-insoluble fractions in vivo. Bull Exp Biol Med 152(6):731\u2013733.https:\/\/doi.org\/10.1007\/s10517-012-1618-7","DOI":"10.1007\/s10517-012-1618-7"},{"key":"2450_CR56","doi-asserted-by":"publisher","unstructured":"Vogels OJ, Veltman J, Oyen WJ et al (2000) Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration. J Neurol Sci. 180(1-2):62\u201365. https:\/\/doi.org\/10.1016\/s0022-510x(00)00429-9","DOI":"10.1016\/s0022-510x(00)00429-9"},{"key":"2450_CR57","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.3390\/biomedicines11123282","volume":"11","author":"V Vorobyov","year":"2023","unstructured":"Vorobyov V, Deev A, Morozova O et al (2023) Early effects of Alpha-Synuclein depletion by pan-neuronal inactivation of encoding gene on electroencephalogram coherence between different brain regions in mice. Biomedicines 11:3282. https:\/\/doi.org\/10.3390\/biomedicines11123282","journal-title":"Biomedicines"},{"key":"2450_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JAD-201472","volume":"81","author":"V Vorobyov","year":"2021","unstructured":"Vorobyov V, Deev A, Sengpiel F et al (2021) Cortical and striatal electroencephalograms and apomorphine effects in the FUS mouse model of amyotrophic lateral sclerosis. J Alzheimers Dis 81:1429\u20131443. https:\/\/doi.org\/10.3233\/JAD-201472","journal-title":"J Alzheimers Dis"},{"key":"2450_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12859-019-2692-x","volume":"20","author":"A Zandon\u00e0","year":"2019","unstructured":"Zandon\u00e0 A, Vasta R, Chi\u00f2 A, Di Camillo B (2019) A dynamic Bayesian network model for the simulation of amyotrophic lateral sclerosis progression. BMC Bioinformatics 20:118. https:\/\/doi.org\/10.1186\/s12859-019-2692-x","journal-title":"BMC Bioinformatics"},{"key":"2450_CR60","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang S, Wang R, Wang G (2019) Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem Neurosci 10:945\u2013953. https:\/\/doi.org\/10.1021\/acschemneuro.8b00454","journal-title":"ACS Chem Neurosci"},{"key":"2450_CR61","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1007\/s12035-022-03048-2","volume":"59","author":"B Zhou","year":"2022","unstructured":"Zhou B, Zheng Y, Li X et al (2022) FUS mutation causes disordered lipid metabolism in skeletal muscle associated with ALS. Mol Neurobiol 59:7265\u20137277. https:\/\/doi.org\/10.1007\/s12035-022-03048-2","journal-title":"Mol Neurobiol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02450-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:42:57Z","timestamp":1774402977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02450-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02450-4","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}}],"article-number":"8"}}